Breast cancer, a heterogeneous disease, is generally classified into three subtypes according to the receptor expression: estrogen receptor/progesterone receptor (ER+/PR+), human epidermal growth factor receptor (HER2+) and without the three markers expression (ER−/PR−/HER2−, triple negative)1. Here, ERBB2 is linked to breast carcinoma.